Lyrica 75 mg Norge - norsk - Statens legemiddelverk

lyrica 75 mg

orifarm as - pregabalin - kapsel, hard - 75 mg

Lyrica 150 mg Norge - norsk - Statens legemiddelverk

lyrica 150 mg

orifarm as - pregabalin - kapsel, hard - 150 mg

Lyrica 150 mg Norge - norsk - Statens legemiddelverk

lyrica 150 mg

farmagon - pregabalin - kapsel, hard - 150 mg

Lyrica 300 mg Norge - norsk - Statens legemiddelverk

lyrica 300 mg

farmagon - pregabalin - kapsel, hard - 300 mg

Lyrica 20 mg/ ml Norge - norsk - Statens legemiddelverk

lyrica 20 mg/ ml

orifarm as - pregabalin - mikstur, oppløsning - 20 mg/ ml

Neurontin 400 mg Norge - norsk - Statens legemiddelverk

neurontin 400 mg

farmagon - gabapentin - kapsel, hard - 400 mg

Neurontin 300 mg Norge - norsk - Statens legemiddelverk

neurontin 300 mg

farmagon - gabapentin - kapsel, hard - 300 mg

Xtandi Den europeiske union - norsk - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Empressin 20 IE/ ml Norge - norsk - Statens legemiddelverk

empressin 20 ie/ ml

orpha-devel handels und vertriebs gmbh - argipressinmonoacetat - konsentrat til infusjonsvæske, oppløsning - 20 ie/ ml

Mometason Glenmark 1 mg/ g Norge - norsk - Statens legemiddelverk

mometason glenmark 1 mg/ g

glenmark arzneimittel gmbh - mometasonfuroat - krem - 1 mg/ g